Clinical Trial

Safety and Efficacy of Balloon Pulmonary Angioplasty in China

Recruiting
View on ClinicalTrials.gov →
Summary
Balloon pulmonary angioplasty (BPA) is a potential treatment for non-operable patients with chronic thromboembolic pulmonary hypertension (CTEPH). The aim of this study was to evaluate the safety and efficacy of BPA in CTEPH patients not amenable to pulmonary endarterectomy(PEA) or suffered from persistent CTEPH after PEA.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2019-12-18; most recent amendment 2023-12-14.
Trial Details
NCT Number NCT04206852
Lead Sponsor Chinese Pulmonary Vascular Disease Research Group
Conditions Chronic Thromboembolic Pulmonary Hypertension
Enrollment 200 participants
Start Date 2018-05-11
Primary Completion 2028-05-11 (estimated)
Study Completion 2028-05-11 (estimated)
Updated on ClinicalTrials.gov 2023-12-20